The hypoxia marker CAIX is prognostic in the UK phase III VorteX-Biobank cohort: an important resource for translational research in soft tissue sarcoma
暂无分享,去创建一个
L. Billingham | R. Grimer | B. Seddon | C. West | D. Roberts | J. Irlam | A. Choudhury | M. Robinson | H. Valentine | L. Forker | P. Shenjere | A. Hughes | S. Sioletic | P. Gaunt | David Hughes | Robert Potter